PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25398453-15	2015	CONCLUSIONS: Lapatinib has antiproliferative effects in a subgroup of HER2(-) nonamplified tumors characterized by high HER3 expression.	Lapatinib	13-22	erb-b2 receptor tyrosine kinase 3	Homo sapiens	120-124	
25398453-16	2015	The possible role of high HER2:HER3 heterodimers in predicting response to lapatinib merits investigation in HER2(-) tumors.	Lapatinib	75-84	erb-b2 receptor tyrosine kinase 3	Homo sapiens	31-35